REQUEST A DEMO
Total
USD $0.00
« Back to previous page

India Pharma and Healthcare Sector Report 2019/2023

An EMIS Insights Industry Report
EMIS is an ISI Emerging Markets Group Company
Date: March 2019
Pages: 91
Available in: English

India’s is the world’s 10th-largest pharmaceutical market in US dollar terms - with sales of over USD 25bn in 2017 - and the largest generic drug manufacturer and exporter globally. Strong domestic demand and robust exports have contributed equally to growth in turnover. Generic drugs account for around 75% of the Indian pharmaceutical market by volume, as well as most of the drug production in the country. The Indian pharmaceutical space is highly fragmented, with nearly 10,000 players. The Indian healthcare industry comprises five broad segments - Healthcare Delivery (Hospitals), Pharmaceuticals, Medical Equipment & Supplies, and Health Insurance and Diagnostics. Healthcare Delivery (Hospitals) accounted for nearly 70% of industry revenue in FY2018. Private hospitals dominate healthcare provision in the country, as public healthcare services and expenditure are highly inadequate.  

 

This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for India . EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

The report also includes a separate chapter with 5-year forecasts for the main sectoral and macroeconomic indicators, delivered in the form of both time series and analytical commentaries.

What this report allows you to do:

  • Understand the key elements at play in the healthcare and pharmaceutical sector in India
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in India
  • Crystallise the forces both driving and restraining this sector in India
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in India
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).

 

See below for a complete table of report contents:

India Pharma and Healthcare Sector Report 2019/2023 - Page 1
Buy full report USD 995.00 Payment methods include:

DOWNLOAD A SAMPLE
Have a question?

Email us at: customerenquiries@emis.com

SEE BELOW FOR A COMPLETE TABLE OF REPORT CONTENTS:

India Pharma and Healthcare Sector Report 2019/2023 -  Page 3
India Pharma and Healthcare Sector Report 2019/2023 -  Page 4
India Pharma and Healthcare Sector Report 2019/2023 -  Page 17
India Pharma and Healthcare Sector Report 2019/2023 -  Page 41
ONCE YOU HAVE COMPLETED YOUR PURCHASE,
YOU WILL BE ABLE TO DOWNLOAD THIS REPORT IMMEDIATELY AS A PDF
If you have any questions, please contact customerenquires@emis.com
Buy full report
Need ongoing access to company, industry or country information?